Skip to search formSkip to main contentSkip to account menu

SDAI

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
AB0449 Sdai reduction at week 2 predict the sdai remission at week 24 when certolizumab pegol (CZP) was administered to patients with rheumatoid arthritis
  • Rheumatoid arthritis – biological DMARDs
  • 2018
  • Corpus ID: 264632776
Background Certolizumab pegol (CZP) is approved for treatment of rheumatoid arthritis. Objectives To explore the predictor of… 
2005
2005
Новые подходы к оценке активности ревматоидного артрита: упрощенный индекс активности болезни sdai (simplified disease activity index) при раннем артрите
Objective. To assess significance of Simplified Disease Activity Index (SDAI) in early arthritis. Material and methods. 76 pts… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)